Share Price and Basic Stock Data
Last Updated: November 8, 2025, 3:43 am
| PEG Ratio | -0.39 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Rana Sugars Ltd operates within the sugar industry, focusing on the production and sale of sugar products. The company’s latest reported share price stood at ₹14.3, with a market capitalization of ₹220 Cr. Over the fiscal year ending March 2025, Rana Sugars recorded total sales of ₹1,713 Cr, showing a growth trajectory from ₹1,627 Cr in the previous year. Quarterly sales figures displayed variability, with the highest quarterly sales of ₹499.94 Cr noted in June 2023, followed by a decline to ₹340.13 Cr in September 2023. This fluctuation indicates the seasonal nature of sugar production, which often sees peaks aligned with harvest cycles. The company’s operational performance is reflected in its total revenue from operations per share, which rose to ₹111.55 for the fiscal year ending March 2025, compared to ₹103.73 in March 2024. This growth in revenue underscores Rana Sugars’ potential in a competitive market, although the pressures from fluctuating sugar prices and production costs remain pertinent challenges.
Profitability and Efficiency Metrics
Rana Sugars’ profitability metrics indicate a mixed performance. The operating profit margin (OPM) for the fiscal year ended March 2025 was reported at 4%, a decline from 7% in the prior year. This decrease reflects the company’s struggle with rising operational expenses, which stood at ₹1,638 Cr for the same period. Despite these challenges, the company managed to report a net profit of ₹34 Cr, a slight increase from ₹28 Cr in March 2024. The interest coverage ratio (ICR) was recorded at 3.12x, suggesting that the company can comfortably meet its interest obligations. However, the return on equity (ROE) at 5.99% is below the sector average, indicating lower profitability relative to shareholder equity. The cash conversion cycle (CCC) stood at 91 days, indicating a relatively efficient management of working capital, although improvements in receivables and inventory management could enhance profitability further.
Balance Sheet Strength and Financial Ratios
Rana Sugars’ balance sheet reflects a mixed scenario of financial health. The company reported total borrowings of ₹435 Cr against reserves of ₹394 Cr, resulting in a total debt-to-equity ratio of 0.68, which is relatively high in comparison to typical industry norms. The book value per share increased to ₹37.47 in March 2025 from ₹33.37 in March 2024, signalling a positive trend in shareholder equity. However, the current ratio of 1.12 suggests that while the company can meet its short-term liabilities, it operates with limited liquidity. The long-term debt-to-equity ratio at 0.15 indicates a conservative approach to leveraging, which could be beneficial in managing financial risks. The enterprise value (EV) was reported at ₹528.84 Cr, with an EV to EBITDA ratio of 5.04, reflecting a moderate valuation relative to earnings before interest, taxes, depreciation, and amortization. Overall, while Rana Sugars maintains a manageable level of debt, its ability to generate consistent profits remains a critical focus.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Rana Sugars demonstrates a strong public presence, with public shareholders owning 75.70% of the company as of June 2023. Promoters hold a consistent 22.64% stake, reflecting stability in ownership. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold negligible stakes, standing at 0.00% and 0.00%, respectively, indicating a lack of institutional confidence. The number of shareholders has gradually increased to 1,22,230, suggesting growing interest from retail investors. Despite the low institutional ownership, the steady promoter holding may reassure investors about the company’s governance and long-term vision. The lack of dividend payouts over the years signals a focus on reinvesting profits for growth rather than returning cash to shareholders, which may appeal to growth-oriented investors but could deter those seeking immediate returns.
Outlook, Risks, and Final Insight
The outlook for Rana Sugars appears cautiously optimistic, given its recent revenue growth and stable shareholder structure. However, several risks loom, including the volatility of sugar prices and rising operational costs, which could adversely affect profitability. The company’s reliance on a single commodity sector exposes it to market fluctuations and regulatory changes that could impact margins. Additionally, the high debt levels may limit financial flexibility in times of economic downturns. Strengths include its solid market position within the sugar sector and an efficient cash conversion cycle, which could enhance liquidity. In scenarios where sugar prices stabilize or improve, the company could see enhanced profitability. Conversely, prolonged high costs or adverse market conditions could hinder growth prospects. Overall, Rana Sugars must navigate these challenges to leverage its growth potential effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Rana Sugars Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gayatri Sugars Ltd | 106 Cr. | 14.3 | 18.8/7.02 | 664 | 11.4 | 0.00 % | 36.6 % | % | 10.0 |
| Dhampure Speciality Sugars Ltd | 73.5 Cr. | 88.3 | 142/82.0 | 23.8 | 41.0 | 0.00 % | 11.6 % | 8.88 % | 10.0 |
| Dhampur Bio Organics Ltd | 504 Cr. | 75.8 | 138/57.3 | 152 | 1.65 % | 3.97 % | 1.56 % | 10.0 | |
| DCM Shriram Industries Ltd | 1,366 Cr. | 157 | 214/142 | 22.4 | 105 | 1.27 % | 13.7 % | 11.8 % | 2.00 |
| Davangere Sugar Company Ltd | 545 Cr. | 3.81 | 12.6/3.03 | 48.2 | 2.45 | 0.00 % | 6.70 % | 3.17 % | 1.00 |
| Industry Average | 1,768.14 Cr | 268.68 | 52.54 | 230.56 | 0.66% | 8.62% | 7.89% | 6.37 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 427.36 | 378.05 | 370.45 | 451.62 | 499.94 | 340.13 | 337.16 | 415.39 | 462.04 | 385.57 | 390.35 | 474.84 | 530.90 |
| Expenses | 404.09 | 370.28 | 345.69 | 394.09 | 467.05 | 344.75 | 318.90 | 379.14 | 442.53 | 393.39 | 370.54 | 435.28 | 523.99 |
| Operating Profit | 23.27 | 7.77 | 24.76 | 57.53 | 32.89 | -4.62 | 18.26 | 36.25 | 19.51 | -7.82 | 19.81 | 39.56 | 6.91 |
| OPM % | 5.45% | 2.06% | 6.68% | 12.74% | 6.58% | -1.36% | 5.42% | 8.73% | 4.22% | -2.03% | 5.07% | 8.33% | 1.30% |
| Other Income | 8.94 | 4.44 | 0.55 | 9.47 | 3.68 | 5.50 | 2.90 | 5.82 | 3.33 | 1.79 | 8.78 | 19.87 | 8.14 |
| Interest | 4.94 | 4.38 | 3.71 | 9.88 | 7.90 | 5.63 | 5.48 | 9.36 | 10.69 | 7.40 | 6.27 | 9.24 | 9.87 |
| Depreciation | 7.49 | 6.98 | 7.47 | 9.40 | 7.83 | 8.33 | 8.22 | 10.96 | 9.24 | 9.09 | -1.48 | 10.26 | 9.12 |
| Profit before tax | 19.78 | 0.85 | 14.13 | 47.72 | 20.84 | -13.08 | 7.46 | 21.75 | 2.91 | -22.52 | 23.80 | 39.93 | -3.94 |
| Tax % | 21.03% | 0.00% | 88.89% | 4.92% | 26.25% | 11.62% | 26.27% | 0.28% | 34.71% | -34.37% | 40.29% | 0.33% | -35.79% |
| Net Profit | 15.63 | 0.84 | 1.57 | 45.36 | 15.37 | -14.60 | 5.50 | 21.70 | 1.90 | -14.78 | 14.20 | 39.80 | -2.53 |
| EPS in Rs | 1.02 | 0.05 | 0.10 | 2.95 | 1.00 | -0.95 | 0.36 | 1.41 | 0.12 | -0.96 | 0.92 | 2.59 | -0.16 |
Last Updated: August 20, 2025, 4:40 am
Below is a detailed analysis of the quarterly data for Rana Sugars Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 530.90 Cr.. The value appears strong and on an upward trend. It has increased from 474.84 Cr. (Mar 2025) to 530.90 Cr., marking an increase of 56.06 Cr..
- For Expenses, as of Jun 2025, the value is 523.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 435.28 Cr. (Mar 2025) to 523.99 Cr., marking an increase of 88.71 Cr..
- For Operating Profit, as of Jun 2025, the value is 6.91 Cr.. The value appears to be declining and may need further review. It has decreased from 39.56 Cr. (Mar 2025) to 6.91 Cr., marking a decrease of 32.65 Cr..
- For OPM %, as of Jun 2025, the value is 1.30%. The value appears to be declining and may need further review. It has decreased from 8.33% (Mar 2025) to 1.30%, marking a decrease of 7.03%.
- For Other Income, as of Jun 2025, the value is 8.14 Cr.. The value appears to be declining and may need further review. It has decreased from 19.87 Cr. (Mar 2025) to 8.14 Cr., marking a decrease of 11.73 Cr..
- For Interest, as of Jun 2025, the value is 9.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.24 Cr. (Mar 2025) to 9.87 Cr., marking an increase of 0.63 Cr..
- For Depreciation, as of Jun 2025, the value is 9.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.26 Cr. (Mar 2025) to 9.12 Cr., marking a decrease of 1.14 Cr..
- For Profit before tax, as of Jun 2025, the value is -3.94 Cr.. The value appears to be declining and may need further review. It has decreased from 39.93 Cr. (Mar 2025) to -3.94 Cr., marking a decrease of 43.87 Cr..
- For Tax %, as of Jun 2025, the value is -35.79%. The value appears to be improving (decreasing) as expected. It has decreased from 0.33% (Mar 2025) to -35.79%, marking a decrease of 36.12%.
- For Net Profit, as of Jun 2025, the value is -2.53 Cr.. The value appears to be declining and may need further review. It has decreased from 39.80 Cr. (Mar 2025) to -2.53 Cr., marking a decrease of 42.33 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.16. The value appears to be declining and may need further review. It has decreased from 2.59 (Mar 2025) to -0.16, marking a decrease of 2.75.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 648 | 698 | 856 | 1,091 | 977 | 1,092 | 1,313 | 1,222 | 1,400 | 1,627 | 1,593 | 1,713 | 1,782 |
| Expenses | 564 | 674 | 717 | 1,012 | 940 | 1,049 | 1,229 | 1,095 | 1,222 | 1,511 | 1,506 | 1,638 | 1,723 |
| Operating Profit | 84 | 24 | 139 | 79 | 37 | 42 | 84 | 126 | 178 | 116 | 87 | 75 | 58 |
| OPM % | 13% | 3% | 16% | 7% | 4% | 4% | 6% | 10% | 13% | 7% | 5% | 4% | 3% |
| Other Income | -0 | 8 | 1 | 2 | 7 | 15 | 231 | 77 | -13 | 21 | 14 | 30 | 39 |
| Interest | 80 | 87 | 95 | 90 | 99 | 94 | 22 | 18 | 29 | 23 | 28 | 34 | 33 |
| Depreciation | 33 | 27 | 28 | 28 | 31 | 33 | 34 | 27 | 28 | 31 | 35 | 27 | 27 |
| Profit before tax | -30 | -82 | 17 | -38 | -87 | -69 | 259 | 158 | 109 | 82 | 37 | 44 | 37 |
| Tax % | -19% | -33% | -0% | 19% | -1% | 8% | -3% | -0% | 22% | 23% | 24% | 22% | |
| Net Profit | -24 | -55 | 17 | -45 | -86 | -75 | 266 | 158 | 85 | 63 | 28 | 34 | 37 |
| EPS in Rs | -1.56 | -3.58 | 1.09 | -2.94 | -5.63 | -4.88 | 17.30 | 10.27 | 5.55 | 4.13 | 1.82 | 2.24 | 2.39 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -129.17% | 130.91% | -364.71% | -91.11% | 12.79% | 454.67% | -40.60% | -46.20% | -25.88% | -55.56% | 21.43% |
| Change in YoY Net Profit Growth (%) | 0.00% | 260.08% | -495.61% | 273.59% | 103.90% | 441.88% | -495.27% | -5.60% | 20.32% | -29.67% | 76.98% |
Rana Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 5% |
| 3 Years: | 7% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | -4% |
| 3 Years: | -30% |
| TTM: | 153% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | -17% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 8% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 1:00 pm
Balance Sheet
Last Updated: October 10, 2025, 2:50 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 |
| Reserves | 43 | -12 | 5 | -54 | -169 | -243 | 23 | 181 | 267 | 331 | 359 | 394 |
| Borrowings | 810 | 824 | 864 | 841 | 865 | 874 | 303 | 207 | 222 | 412 | 443 | 435 |
| Other Liabilities | 330 | 344 | 417 | 258 | 537 | 562 | 583 | 594 | 648 | 566 | 548 | 539 |
| Total Liabilities | 1,336 | 1,310 | 1,440 | 1,199 | 1,387 | 1,346 | 1,064 | 1,136 | 1,290 | 1,462 | 1,503 | 1,522 |
| Fixed Assets | 453 | 439 | 447 | 455 | 450 | 431 | 378 | 421 | 452 | 521 | 579 | 568 |
| CWIP | 32 | 34 | 29 | 28 | 21 | 30 | 38 | 28 | 57 | 14 | 6 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 851 | 836 | 964 | 717 | 916 | 886 | 648 | 688 | 781 | 926 | 918 | 948 |
| Total Assets | 1,336 | 1,310 | 1,440 | 1,199 | 1,387 | 1,346 | 1,064 | 1,136 | 1,290 | 1,462 | 1,503 | 1,522 |
Below is a detailed analysis of the balance sheet data for Rana Sugars Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 154.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 154.00 Cr..
- For Reserves, as of Mar 2025, the value is 394.00 Cr.. The value appears strong and on an upward trend. It has increased from 359.00 Cr. (Mar 2024) to 394.00 Cr., marking an increase of 35.00 Cr..
- For Borrowings, as of Mar 2025, the value is 435.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 443.00 Cr. (Mar 2024) to 435.00 Cr., marking a decrease of 8.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 539.00 Cr.. The value appears to be improving (decreasing). It has decreased from 548.00 Cr. (Mar 2024) to 539.00 Cr., marking a decrease of 9.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,522.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,503.00 Cr. (Mar 2024) to 1,522.00 Cr., marking an increase of 19.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 568.00 Cr.. The value appears to be declining and may need further review. It has decreased from 579.00 Cr. (Mar 2024) to 568.00 Cr., marking a decrease of 11.00 Cr..
- For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 948.00 Cr.. The value appears strong and on an upward trend. It has increased from 918.00 Cr. (Mar 2024) to 948.00 Cr., marking an increase of 30.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,522.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,503.00 Cr. (Mar 2024) to 1,522.00 Cr., marking an increase of 19.00 Cr..
However, the Borrowings (435.00 Cr.) are higher than the Reserves (394.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -726.00 | -800.00 | -725.00 | -762.00 | -828.00 | -832.00 | -219.00 | -81.00 | -44.00 | -296.00 | -356.00 | -360.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33 | 30 | 32 | 24 | 52 | 46 | 40 | 41 | 28 | 29 | 32 | 46 |
| Inventory Days | 516 | 387 | 401 | 168 | 231 | 207 | 104 | 151 | 196 | 180 | 176 | 156 |
| Days Payable | 150 | 129 | 163 | 59 | 196 | 202 | 157 | 201 | 201 | 132 | 130 | 111 |
| Cash Conversion Cycle | 399 | 288 | 270 | 133 | 88 | 51 | -12 | -9 | 23 | 77 | 78 | 91 |
| Working Capital Days | -26 | -51 | -36 | -59 | -113 | -131 | -37 | -14 | 8 | 11 | 5 | 9 |
| ROCE % | 5% | 1% | 11% | 5% | 1% | 3% | 9% | 20% | 26% | 13% | 7% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.24 | 1.82 | 4.13 | 5.55 | 10.27 |
| Diluted EPS (Rs.) | 2.24 | 1.82 | 4.13 | 5.55 | 10.27 |
| Cash EPS (Rs.) | 4.00 | 4.12 | 6.17 | 7.36 | 12.03 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 37.47 | 33.37 | 31.54 | 27.41 | 21.82 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 37.47 | 33.37 | 31.54 | 27.41 | 21.82 |
| Revenue From Operations / Share (Rs.) | 111.55 | 103.73 | 106.00 | 91.20 | 79.59 |
| PBDIT / Share (Rs.) | 6.83 | 6.56 | 8.90 | 11.84 | 8.57 |
| PBIT / Share (Rs.) | 5.06 | 4.25 | 6.86 | 10.03 | 6.81 |
| PBT / Share (Rs.) | 2.87 | 2.41 | 5.37 | 7.10 | 10.26 |
| Net Profit / Share (Rs.) | 2.24 | 1.82 | 4.13 | 5.55 | 10.27 |
| PBDIT Margin (%) | 6.12 | 6.32 | 8.40 | 12.97 | 10.76 |
| PBIT Margin (%) | 4.53 | 4.10 | 6.47 | 10.99 | 8.55 |
| PBT Margin (%) | 2.57 | 2.32 | 5.06 | 7.78 | 12.89 |
| Net Profit Margin (%) | 2.00 | 1.75 | 3.89 | 6.08 | 12.90 |
| Return on Networth / Equity (%) | 5.97 | 5.45 | 13.09 | 20.24 | 47.07 |
| Return on Capital Employeed (%) | 10.72 | 9.41 | 15.36 | 25.29 | 21.67 |
| Return On Assets (%) | 2.25 | 1.86 | 4.33 | 6.60 | 13.87 |
| Long Term Debt / Equity (X) | 0.15 | 0.13 | 0.18 | 0.22 | 0.27 |
| Total Debt / Equity (X) | 0.68 | 0.73 | 0.72 | 0.39 | 0.47 |
| Asset Turnover Ratio (%) | 1.13 | 1.07 | 1.18 | 1.15 | 1.11 |
| Current Ratio (X) | 1.12 | 1.07 | 1.11 | 1.11 | 1.05 |
| Quick Ratio (X) | 0.40 | 0.33 | 0.35 | 0.35 | 0.47 |
| Inventory Turnover Ratio (X) | 2.20 | 2.04 | 2.33 | 2.53 | 2.94 |
| Interest Coverage Ratio (X) | 3.12 | 3.55 | 5.97 | 6.30 | 7.15 |
| Interest Coverage Ratio (Post Tax) (X) | 2.02 | 1.99 | 3.77 | 4.52 | 5.69 |
| Enterprise Value (Cr.) | 528.84 | 668.18 | 681.88 | 585.60 | 249.95 |
| EV / Net Operating Revenue (X) | 0.30 | 0.41 | 0.41 | 0.41 | 0.20 |
| EV / EBITDA (X) | 5.04 | 6.64 | 4.99 | 3.22 | 1.90 |
| MarketCap / Net Operating Revenue (X) | 0.10 | 0.18 | 0.20 | 0.31 | 0.12 |
| Price / BV (X) | 0.32 | 0.57 | 0.69 | 1.04 | 0.44 |
| Price / Net Operating Revenue (X) | 0.10 | 0.18 | 0.20 | 0.31 | 0.12 |
| EarningsYield | 0.18 | 0.09 | 0.18 | 0.19 | 1.07 |
After reviewing the key financial ratios for Rana Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.24. This value is below the healthy minimum of 5. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.00. This value is within the healthy range. It has decreased from 4.12 (Mar 24) to 4.00, marking a decrease of 0.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 37.47. It has increased from 33.37 (Mar 24) to 37.47, marking an increase of 4.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 37.47. It has increased from 33.37 (Mar 24) to 37.47, marking an increase of 4.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 111.55. It has increased from 103.73 (Mar 24) to 111.55, marking an increase of 7.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.83. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 6.83, marking an increase of 0.27.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.06. This value is within the healthy range. It has increased from 4.25 (Mar 24) to 5.06, marking an increase of 0.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.87. This value is within the healthy range. It has increased from 2.41 (Mar 24) to 2.87, marking an increase of 0.46.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.24. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 2.24, marking an increase of 0.42.
- For PBDIT Margin (%), as of Mar 25, the value is 6.12. This value is below the healthy minimum of 10. It has decreased from 6.32 (Mar 24) to 6.12, marking a decrease of 0.20.
- For PBIT Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 10. It has increased from 4.10 (Mar 24) to 4.53, marking an increase of 0.43.
- For PBT Margin (%), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 10. It has increased from 2.32 (Mar 24) to 2.57, marking an increase of 0.25.
- For Net Profit Margin (%), as of Mar 25, the value is 2.00. This value is below the healthy minimum of 5. It has increased from 1.75 (Mar 24) to 2.00, marking an increase of 0.25.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.97. This value is below the healthy minimum of 15. It has increased from 5.45 (Mar 24) to 5.97, marking an increase of 0.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.72. This value is within the healthy range. It has increased from 9.41 (Mar 24) to 10.72, marking an increase of 1.31.
- For Return On Assets (%), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. It has increased from 1.86 (Mar 24) to 2.25, marking an increase of 0.39.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.13 (Mar 24) to 0.15, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has decreased from 0.73 (Mar 24) to 0.68, marking a decrease of 0.05.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.13. It has increased from 1.07 (Mar 24) to 1.13, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.12. This value is below the healthy minimum of 1.5. It has increased from 1.07 (Mar 24) to 1.12, marking an increase of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.33 (Mar 24) to 0.40, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 4. It has increased from 2.04 (Mar 24) to 2.20, marking an increase of 0.16.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.12. This value is within the healthy range. It has decreased from 3.55 (Mar 24) to 3.12, marking a decrease of 0.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. It has increased from 1.99 (Mar 24) to 2.02, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 528.84. It has decreased from 668.18 (Mar 24) to 528.84, marking a decrease of 139.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 24) to 0.30, marking a decrease of 0.11.
- For EV / EBITDA (X), as of Mar 25, the value is 5.04. This value is within the healthy range. It has decreased from 6.64 (Mar 24) to 5.04, marking a decrease of 1.60.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
- For Price / BV (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has decreased from 0.57 (Mar 24) to 0.32, marking a decrease of 0.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
- For EarningsYield, as of Mar 25, the value is 0.18. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.18, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rana Sugars Ltd:
- Net Profit Margin: 2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.72% (Industry Average ROCE: 8.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.97% (Industry Average ROE: 7.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.4
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 5.99 (Industry average Stock P/E: 52.54)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.68
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | SCO 49-50, Sector 8-C, Chandigarh Chandigarh 160009 | info@ranasugars.com http://www.ranasugars.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rana Ranjit Singh | Chairman & Non-Exe.Director |
| Mr. Rana Veer Pratap Singh | Managing Director |
| Mr. Surjeet Kaushal | Ind. Non-Executive Director |
| Ms. Navpreet Kaur | Ind. Non-Executive Director |
| Mr. Harneet Singh Oberoi | Ind. Non-Executive Director |
| Mr. Anil Singh Negi | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Rana Sugars Ltd?
Rana Sugars Ltd's intrinsic value (as of 08 November 2025) is 10.42 which is 27.13% lower the current market price of 14.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 220 Cr. market cap, FY2025-2026 high/low of 20.8/11.1, reserves of ₹394 Cr, and liabilities of 1,522 Cr.
What is the Market Cap of Rana Sugars Ltd?
The Market Cap of Rana Sugars Ltd is 220 Cr..
What is the current Stock Price of Rana Sugars Ltd as on 08 November 2025?
The current stock price of Rana Sugars Ltd as on 08 November 2025 is 14.3.
What is the High / Low of Rana Sugars Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rana Sugars Ltd stocks is 20.8/11.1.
What is the Stock P/E of Rana Sugars Ltd?
The Stock P/E of Rana Sugars Ltd is 5.99.
What is the Book Value of Rana Sugars Ltd?
The Book Value of Rana Sugars Ltd is 35.6.
What is the Dividend Yield of Rana Sugars Ltd?
The Dividend Yield of Rana Sugars Ltd is 0.00 %.
What is the ROCE of Rana Sugars Ltd?
The ROCE of Rana Sugars Ltd is 7.67 %.
What is the ROE of Rana Sugars Ltd?
The ROE of Rana Sugars Ltd is 5.99 %.
What is the Face Value of Rana Sugars Ltd?
The Face Value of Rana Sugars Ltd is 10.0.